Charles Schwab Investment Management »

Compass Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $384k 246k 1.56
2023-09-30 $519k 263k 1.97
2023-06-30 $799k 251k 3.18
2023-03-31 $140k 43k 3.27
2022-12-31 $215k 43k 5.03
2022-09-30 $73k 32k 2.30